ADAM8 Protein (AA 1-653) (His tag)
-
- Target Alle ADAM8 Proteine anzeigen
- ADAM8 (ADAM Metallopeptidase Domain 8 (ADAM8))
- Protein-Typ
- Recombinant
- Proteineigenschaft
- AA 1-653
-
Spezies
- Human
-
Quelle
- HEK-293 Cells
- Aufreinigungstag / Konjugat
- Dieses ADAM8 Protein ist gelabelt mit His tag.
- Sequenz
- Met1-Ser653
- Produktmerkmale
- A DNA sequence encoding the Human ADAM8 protein (P78325) (Met1-Ser653) was expressed with a C-His.
- Reinheit
- > 95 % as determined by reducing SDS-PAGE.
- Top Product
- Discover our top product ADAM8 Protein
-
-
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
-
Lyophilized from sterile PBS, pH 7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01 % Tween80 are added as protectants before lyophilization. - Lagerung
- 4 °C,-20 °C,-80 °C
- Informationen zur Lagerung
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
- Haltbarkeit
- 12 months
-
- Target
- ADAM8 (ADAM Metallopeptidase Domain 8 (ADAM8))
- Andere Bezeichnung
- ADAM8 (ADAM8 Produkte)
- Hintergrund
-
Abbreviation: ADAM8,CD156a
Target Synonym: Disintegrin and metalloproteinase domain-containing protein 8,ADAM 8,EC 3.4.24.,Cell surface antigen MS2,CD antigen CD156a,MS2
Background: ADAM8, also known as cell surface antigen MS2 or CD156a, is a member of the ADAM family that contains a disintegrin and metalloprotease-like domain. ADAM8 can cleave a variety of substrates and has been shown as a sheddase for the low affinity IgE receptor CD23 and the neural recognition molecule CHL1. Expression and regulation studies suggest that ADAM8 is a novel osteoclast stimulating factor and may play a role in asthma. It can be activated and assayed under the conditions described in the Activity Assay Protocol.
- Molekulargewicht
-
Calculated MW: 71.72 kDa
Observed MW: 60 kDa
- UniProt
- P78325
- Pathways
- Activation of Innate immune Response, M Phase
-